Safety, Efficacy, and Immunogenicity of 2 Doses of Bovine‐Human (UK) and Rhesus–Rhesus‐Human Rotavirus Reassortant Tetravalent Vaccines in Finnish Children | Zendy

Timo Vesikari | Zendy; Aino Karvonen | Zendy; Jukka Majuri | Zendy; ShangQin Zeng | Zendy; Xiaoli Pang | Zendy; Robert Kohberger | Zendy; Bruce D. Forrest | Zendy; Yasutaka Hoshino | Zendy; Robert M. Chanock | Zendy; Albert Z. Kapikian | Zendy

Open Access

Safety, Efficacy, and Immunogenicity of 2 Doses of Bovine‐Human (UK) and Rhesus–Rhesus‐Human Rotavirus Reassortant Tetravalent Vaccines in Finnish Children

Author(s) -

Timo Vesikari,

Aino Karvonen,

Jukka Majuri,

ShangQin Zeng,

Xiaoli Pang,

Robert Kohberger,

Bruce D. Forrest,

Yasutaka Hoshino,

Robert M. Chanock,

Albert Z. Kapikian

Publication year - 2006

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/505151

Subject(s) - immunogenicity , virology , rotavirus , rotavirus vaccine , reoviridae , medicine , intussusception (medical disorder) , serotype , biology , immunology , antibody , virus , surgery

Live oral rhesus-rhesus-human rotavirus reassortant tetravalent (RRV-TV) vaccine was efficacious against rotavirus gastroenteritis but was withdrawn because of a rare association with intussusception. A corresponding tetravalent (types G1, G2, G3, and G4) reassortant vaccine based on bovine-human (UK) rotavirus reassortant tetravalent (BRV-TV) vaccine was developed concurrently.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research